Get Full access to Top 1000 data, subscribe from only €29

Register Now »
BioMarin develops and commercialises innovative biopharmaceuticals for rare diseases driven by genetic causes.

Financial Data

  • 31st Dec 20 Source: CRO
    • €1.1 billion turnover
    • €92.2 million profit
    • 468 employees
  • 31st Dec 19 Source: CRO
    • €1 billion turnover
    • €42 million profit
    • 434 employees

Ranking

By Turnover

(€1.1 billion)

By Employees

(468)
84th in Top Companies By Turnover
  • 468
  • €1.1 billion

Employees

  • Michael O’Donnell CEO/Managing Director

Latest News

Newsletter

Thanks, You are now signed up to the Top 1000 newsletter!